66 related articles for article (PubMed ID: 12014596)
1. Methylphenidate-related growth impairment.
Holtkamp K; Peters-Wallraf B; Wüller S; Pfäaffle R; Herpertz-Dahlmann B
J Child Adolesc Psychopharmacol; 2002; 12(1):55-61. PubMed ID: 12014596
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate and atomoxetine treatment negatively affect physical growth indexes of school-age children and adolescents with attention-deficit/hyperactivity disorder.
Deng L; Zhou P; Zhu L; Zhang Y; Yang T; Zhao Q; Chen J; Li T; Cheng Q; Chen L
Pharmacol Biochem Behav; 2021 Sep; 208():173225. PubMed ID: 34217783
[TBL] [Abstract][Full Text] [Related]
3. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
[TBL] [Abstract][Full Text] [Related]
4. Potential disturbance of methylphenidate of gonadal hormones or pubescent development in patients with attention-deficit/hyperactivity disorder: A twelve-month follow-up study.
Wang LJ; Huang YH; Chou WJ; Lee SY; Tsai CS; Lee MJ; Chou MC
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110181. PubMed ID: 33227299
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Koonrungsesomboon K; Koonrungsesomboon N
J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):189-197. PubMed ID: 31841645
[No Abstract] [Full Text] [Related]
6. Methylphenidate-Induced Enuresis: 3 Case Reports.
Uzun N; Akinci MA; Karatoprak S
Clin Neuropharmacol; 2021 Jan-Feb 01; 44(1):37-38. PubMed ID: 33252370
[TBL] [Abstract][Full Text] [Related]
7. Choroidal Vascular Index in Patients With Attention-Deficit/Hyperactivity Disorder and Methylphenidate.
Kiziltoprak H; Kocabas DO; Aydemir GA; Kalınlı EM; Aydemir E; Oren B
J Pediatr Ophthalmol Strabismus; 2023; 60(6):411-416. PubMed ID: 36546779
[TBL] [Abstract][Full Text] [Related]
8. Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence.
Krinzinger H; Hall CL; Groom MJ; Ansari MT; Banaschewski T; Buitelaar JK; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Falissard B; Garas P; Inglis SK; Kovshoff H; Kochhar P; McCarthy S; Nagy P; Neubert A; Roberts S; Sayal K; Sonuga-Barke E; Wong ICK; Xia J; Zuddas A; Hollis C; Konrad K; Liddle EB;
Neurosci Biobehav Rev; 2019 Dec; 107():945-968. PubMed ID: 31545988
[TBL] [Abstract][Full Text] [Related]
9. Effect of methylphenidate on height in pediatric attention-deficit hyperactivity disorder patients: a systematic review and meta-analysis.
Duong KL; Yang BR; Yun HY; Chae JW
Eur Child Adolesc Psychiatry; 2024 Jun; 33(6):1755-1770. PubMed ID: 37589730
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic Effects of Chronic Methylphenidate Treatment and Chronic Social Stress in Adults with Attention-Deficit/Hyperactivity Disorder.
Kittel-Schneider S; Spiegel S; Renner T; Romanos M; Reif A; Reichert S; Heupel J; Schnetzler L; Stopper H; Jacob C
Pharmacopsychiatry; 2016 Jul; 49(4):146-54. PubMed ID: 26926233
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project.
Carucci S; Zuddas A; Lampis A; Man KKC; Balia C; Buitelaar J; Danckaerts M; Dittmann RW; Donno F; Falissard B; Gagliano A; Garas P; Häge A; Hollis C; Inglis SK; Konrad K; Kovshoff H; Liddle E; McCarthy S; Neubert A; Nagy P; Rosenthal E; Sonuga-Barke EJS; Wong ICK; Banaschewski T; Coghill D
J Atten Disord; 2024 Mar; 28(5):722-739. PubMed ID: 38366816
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
Naguy A; Elsori D; Alamiri B
J Child Adolesc Psychopharmacol; 2019 Feb; 29(1):75-76. PubMed ID: 30575406
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate associated vitiligo in a child: A case report.
Guler Aksu G; Akdere P; Toros F
Asia Pac Psychiatry; 2019 Sep; 11(3):e12351. PubMed ID: 30821429
[No Abstract] [Full Text] [Related]
14. Lens opacities in children using methylphenidate hydrochloride.
Duman NS; Duman R; Sarı Gökten E; Duman R
Cutan Ocul Toxicol; 2017 Dec; 36(4):362-365. PubMed ID: 28376677
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate Overdose Causing Secondary Polydipsia and Severe Hyponatremia in an 8-Year-Old Boy.
Patel V; Krishna AS; Lefevre C; Kaagaza M; Wittkamp M
Pediatr Emerg Care; 2017 Sep; 33(9):e55-e57. PubMed ID: 27115479
[TBL] [Abstract][Full Text] [Related]
16. The effect of methylphenidate on the dopamine and growth hormone response to exercise in children with attention-deficit hyperactivity disorder.
Nemet D; Ben-Zaken S; Eliakim A
Growth Horm IGF Res; 2024 Jun; 76():101596. PubMed ID: 38820857
[TBL] [Abstract][Full Text] [Related]
17. [Side effects of methylphenidate in children and the young].
Espadas M; Insa I; Chamorro M; Alda-Diez JA
Rev Neurol; 2018 Mar; 66(5):157-162. PubMed ID: 29480512
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate and the Risk of New-Onset Seizures.
Andrade C
J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32726522
[TBL] [Abstract][Full Text] [Related]
19. ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment.
Turan S; Ermiş Ç; Pereira-Sanchez V; Tunctürk M; Pekcanlar AA
Psychopharmacol Bull; 2021 Jun; 51(3):10-26. PubMed ID: 34421141
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate Promotes Premature Growth Plate Closure: In Vitro Evidence.
Pazos-Pérez A; Piñeiro-Ramil M; Franco-Trepat E; Guillán-Fresco M; López-López V; Jorge-Mora A; Alonso-Pérez A; Gómez R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
